Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 30 entries
Sorted by: Best Match Show Resources per page
Add-on histamine receptor-3 antagonist for allergic rhinitis: a double blind randomized crossover trial using the environmental exposure unit.

Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology

North ML, Walker TJ, Steacy LM, Hobsbawn BG, Allan RJ, Hackman F, Sun X, Day AG, Ellis AK.
PMID: 25024716
Allergy Asthma Clin Immunol. 2014 Jul 03;10(1):33. doi: 10.1186/1710-1492-10-33. eCollection 2014.

BACKGROUND: Oral antihistamines that target the histamine receptor-1, such as fexofenadine, offer suboptimal relief of allergic rhinitis-associated nasal congestion. Combinations with oral sympathomimetics, such as pseudoephedrine, relieve congestion but produce side effects. Previous animal and human studies with histamine...

Cite
North ML, Walker TJ, Steacy LM, et al. Add-on histamine receptor-3 antagonist for allergic rhinitis: a double blind randomized crossover trial using the environmental exposure unit. Allergy Asthma Clin Immunol. 2014;10(1):33doi: 10.1186/1710-1492-10-33.
North, M. L., Walker, T. J., Steacy, L. M., Hobsbawn, B. G., Allan, R. J., Hackman, F., Sun, X., Day, A. G., & Ellis, A. K. (2014). Add-on histamine receptor-3 antagonist for allergic rhinitis: a double blind randomized crossover trial using the environmental exposure unit. Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology, 10(1), 33. https://doi.org/10.1186/1710-1492-10-33
North, Michelle L, et al. "Add-on histamine receptor-3 antagonist for allergic rhinitis: a double blind randomized crossover trial using the environmental exposure unit." Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology vol. 10,1 (2014): 33. doi: https://doi.org/10.1186/1710-1492-10-33
North ML, Walker TJ, Steacy LM, Hobsbawn BG, Allan RJ, Hackman F, Sun X, Day AG, Ellis AK. Add-on histamine receptor-3 antagonist for allergic rhinitis: a double blind randomized crossover trial using the environmental exposure unit. Allergy Asthma Clin Immunol. 2014 Jul 03;10(1):33. doi: 10.1186/1710-1492-10-33. eCollection 2014. PMID: 25024716; PMCID: PMC4094756.
Copy Download .nbib Format: NLM
Early Extracorporeal Membrane Oxygenation Support for 5-Fluorouracil-induced Acute Heart Failure with Cardiogenic Shock.

Heart views : the official journal of the Gulf Heart Association

Höllriegel R, Fischer J, Schuler G.
PMID: 24949186
Heart Views. 2014 Jan;15(1):26-8. doi: 10.4103/1995-705X.132144.

A 50-year-old man with no previous history of cardiovascular disease or risk factors was admitted for syncope and orthopnea. Importantly, he underwent recent chemotherapy with 5-fluorouracil (5-FU) until 1 day before his acute presentation. In the emergency room, patient...

Cite
Höllriegel R, Fischer J, Schuler G. Early Extracorporeal Membrane Oxygenation Support for 5-Fluorouracil-induced Acute Heart Failure with Cardiogenic Shock. Heart Views. 2014;15(1):26-8doi: 10.4103/1995-705X.132144.
Höllriegel, R., Fischer, J., & Schuler, G. (2014). Early Extracorporeal Membrane Oxygenation Support for 5-Fluorouracil-induced Acute Heart Failure with Cardiogenic Shock. Heart views : the official journal of the Gulf Heart Association, 15(1), 26-8. https://doi.org/10.4103/1995-705X.132144
Höllriegel, Robert, et al. "Early Extracorporeal Membrane Oxygenation Support for 5-Fluorouracil-induced Acute Heart Failure with Cardiogenic Shock." Heart views : the official journal of the Gulf Heart Association vol. 15,1 (2014): 26-8. doi: https://doi.org/10.4103/1995-705X.132144
Höllriegel R, Fischer J, Schuler G. Early Extracorporeal Membrane Oxygenation Support for 5-Fluorouracil-induced Acute Heart Failure with Cardiogenic Shock. Heart Views. 2014 Jan;15(1):26-8. doi: 10.4103/1995-705X.132144. PMID: 24949186; PMCID: PMC4062987.
Copy Download .nbib Format: NLM
Motion sickness: an overview.

Drugs in context

Leung AK, Hon KL.
PMID: 32158479
Drugs Context. 2019 Dec 13;8. doi: 10.7573/dic.2019-9-4. eCollection 2019.

BACKGROUND: Motion sickness is a common phenomenon that affects almost everybody at some point in their lifetime. Clinicians should be familiar with the proper management of this condition.OBJECTIVE: To provide an update on the current understanding of the pathophysiology...

Cite
Leung AK, Hon KL. Motion sickness: an overview. Drugs Context. 2019;8doi: 10.7573/dic.2019-9-4.
Leung, A. K., & Hon, K. L. (2019). Motion sickness: an overview. Drugs in context, 8. https://doi.org/10.7573/dic.2019-9-4
Leung, Alexander Kc, and Hon, Kam Lun. "Motion sickness: an overview." Drugs in context vol. 8 (2019). doi: https://doi.org/10.7573/dic.2019-9-4
Leung AK, Hon KL. Motion sickness: an overview. Drugs Context. 2019 Dec 13;8. doi: 10.7573/dic.2019-9-4. eCollection 2019. PMID: 32158479; PMCID: PMC7048153.
Copy Download .nbib Format: NLM
Long-term, induced expression of Hand2 in peripheral sympathetic neurons ameliorates sarcopenia in geriatric mice.

Journal of cachexia, sarcopenia and muscle

Rodrigues ACZ, Messi ML, Wang ZM, Bonilla HJ, Freeman WM, Delbono O.
PMID: 34546662
J Cachexia Sarcopenia Muscle. 2021 Dec;12(6):1908-1924. doi: 10.1002/jcsm.12790. Epub 2021 Sep 21.

BACKGROUND: The discovery of adrenoceptors, which mediate the effects of the sympathetic nervous system neurotransmitter norepinephrine on specific tissues, sparked the development of sympathomimetics that have profound influence on skeletal muscle mass. However, chronic administration has serious side effects...

Cite
Rodrigues ACZ, Messi ML, Wang ZM, et al. Long-term, induced expression of Hand2 in peripheral sympathetic neurons ameliorates sarcopenia in geriatric mice. J Cachexia Sarcopenia Muscle. 2021;12(6):1908-1924doi: 10.1002/jcsm.12790.
Rodrigues, A. C. Z., Messi, M. L., Wang, Z. M., Bonilla, H. J., Freeman, W. M., & Delbono, O. (2021). Long-term, induced expression of Hand2 in peripheral sympathetic neurons ameliorates sarcopenia in geriatric mice. Journal of cachexia, sarcopenia and muscle, 12(6), 1908-1924. https://doi.org/10.1002/jcsm.12790
Rodrigues, Anna Carolina Zaia, et al. "Long-term, induced expression of Hand2 in peripheral sympathetic neurons ameliorates sarcopenia in geriatric mice." Journal of cachexia, sarcopenia and muscle vol. 12,6 (2021): 1908-1924. doi: https://doi.org/10.1002/jcsm.12790
Rodrigues ACZ, Messi ML, Wang ZM, Bonilla HJ, Freeman WM, Delbono O. Long-term, induced expression of Hand2 in peripheral sympathetic neurons ameliorates sarcopenia in geriatric mice. J Cachexia Sarcopenia Muscle. 2021 Dec;12(6):1908-1924. doi: 10.1002/jcsm.12790. Epub 2021 Sep 21. PMID: 34546662; PMCID: PMC8718059.
Copy Download .nbib Format: NLM
Severe maculopapular eruption due to pseudoephedrine in a combination drug, with cross-reactivity to phenylephrine.

Contact dermatitis

Gratacós Gómez AR, González Jimenez OM, Palacios Cañas A, Moreno Lozano L, Juan Cencerrado M, Gómez Torrijos E.
PMID: 34313328
Contact Dermatitis. 2021 Dec;85(6):716-717. doi: 10.1111/cod.13951. Epub 2021 Aug 09.

No abstract available.

Cite
Gratacós Gómez AR, González Jimenez OM, Palacios Cañas A, et al. Severe maculopapular eruption due to pseudoephedrine in a combination drug, with cross-reactivity to phenylephrine. Contact Dermatitis. 2021;85(6):716-717doi: 10.1111/cod.13951.
Gratacós Gómez, A. R., González Jimenez, O. M., Palacios Cañas, A., Moreno Lozano, L., Juan Cencerrado, M., & Gómez Torrijos, E. (2021). Severe maculopapular eruption due to pseudoephedrine in a combination drug, with cross-reactivity to phenylephrine. Contact dermatitis, 85(6), 716-717. https://doi.org/10.1111/cod.13951
Gratacós Gómez, Alejandro Raúl, et al. "Severe maculopapular eruption due to pseudoephedrine in a combination drug, with cross-reactivity to phenylephrine." Contact dermatitis vol. 85,6 (2021): 716-717. doi: https://doi.org/10.1111/cod.13951
Gratacós Gómez AR, González Jimenez OM, Palacios Cañas A, Moreno Lozano L, Juan Cencerrado M, Gómez Torrijos E. Severe maculopapular eruption due to pseudoephedrine in a combination drug, with cross-reactivity to phenylephrine. Contact Dermatitis. 2021 Dec;85(6):716-717. doi: 10.1111/cod.13951. Epub 2021 Aug 09. PMID: 34313328.
Copy Download .nbib Format: NLM
Acute Stress Cardiomyopathy: Heart of pheochromocytoma.

Annales d'endocrinologie

Cornu E, Motiejunaite J, Belmihoub I, Vidal-Petiot E, Mirabel M, Amar L.
PMID: 32988608
Ann Endocrinol (Paris). 2021 Jun;82(3):201-205. doi: 10.1016/j.ando.2020.03.011. Epub 2020 Mar 18.

Stress cardiomyopathy (SCM) is a syndrome characterized by transient regional systolic dysfunction of the left ventricle in the absence of angiographic evidence of coronaropathy. This abnormality is associated with high levels of catecholamines. Stress cardiomyopathy is also called Takotsubo...

Cite
Cornu E, Motiejunaite J, Belmihoub I, et al. Acute Stress Cardiomyopathy: Heart of pheochromocytoma. Ann Endocrinol (Paris). 2020;82(3):201-205doi: 10.1016/j.ando.2020.03.011.
Cornu, E., Motiejunaite, J., Belmihoub, I., Vidal-Petiot, E., Mirabel, M., & Amar, L. (2021). Acute Stress Cardiomyopathy: Heart of pheochromocytoma. Annales d'endocrinologie, 82(3), 201-205. https://doi.org/10.1016/j.ando.2020.03.011
Cornu, Erika, et al. "Acute Stress Cardiomyopathy: Heart of pheochromocytoma." Annales d'endocrinologie vol. 82,3 (2021): 201-205. doi: https://doi.org/10.1016/j.ando.2020.03.011
Cornu E, Motiejunaite J, Belmihoub I, Vidal-Petiot E, Mirabel M, Amar L. Acute Stress Cardiomyopathy: Heart of pheochromocytoma. Ann Endocrinol (Paris). 2021 Jun;82(3):201-205. doi: 10.1016/j.ando.2020.03.011. Epub 2020 Mar 18. PMID: 32988608.
Copy Download .nbib Format: NLM
Pediatrician's cough and cold medication prescription for hypothetical cases - A cross-sectional multi-centric study.

Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society

Chandelia S, Dhankar M, Salhan M.
PMID: 27013910
Saudi Pharm J. 2016 Mar;24(2):176-81. doi: 10.1016/j.jsps.2015.02.011. Epub 2015 Mar 19.

BACKGROUND: Concerns over inappropriate use of cough and cold medication (CCM) in children have been raised. In addition to being ineffective, these are now considered toxic for young children. Despite this fact studies from some regions have shown high...

Cite
Chandelia S, Dhankar M, Salhan M. Pediatrician's cough and cold medication prescription for hypothetical cases - A cross-sectional multi-centric study. Saudi Pharm J. 2015;24(2):176-81doi: 10.1016/j.jsps.2015.02.011.
Chandelia, S., Dhankar, M., & Salhan, M. (2016). Pediatrician's cough and cold medication prescription for hypothetical cases - A cross-sectional multi-centric study. Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society, 24(2), 176-81. https://doi.org/10.1016/j.jsps.2015.02.011
Chandelia, Sudha, et al. "Pediatrician's cough and cold medication prescription for hypothetical cases - A cross-sectional multi-centric study." Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society vol. 24,2 (2016): 176-81. doi: https://doi.org/10.1016/j.jsps.2015.02.011
Chandelia S, Dhankar M, Salhan M. Pediatrician's cough and cold medication prescription for hypothetical cases - A cross-sectional multi-centric study. Saudi Pharm J. 2016 Mar;24(2):176-81. doi: 10.1016/j.jsps.2015.02.011. Epub 2015 Mar 19. PMID: 27013910; PMCID: PMC4792892.
Copy Download .nbib Format: NLM
Bronchial asthma: diagnosis and long-term treatment in adults.

Deutsches Arzteblatt international

Ukena D, Fishman L, Niebling WB.
PMID: 19626179
Dtsch Arztebl Int. 2008 May;105(21):385-94. doi: 10.3238/arztebl.2008.0385. Epub 2008 May 23.

INTRODUCTION: Bronchial asthma is a serious global health problem. 5% to 10% of persons of all ages suffer from this chronic airway disorder. This review article presents important considerations of diagnosis and treatment in view of the current national...

Cite
Ukena D, Fishman L, Niebling WB. Bronchial asthma: diagnosis and long-term treatment in adults. Dtsch Arztebl Int. 2008;105(21):385-94doi: 10.3238/arztebl.2008.0385.
Ukena, D., Fishman, L., & Niebling, W. B. (2008). Bronchial asthma: diagnosis and long-term treatment in adults. Deutsches Arzteblatt international, 105(21), 385-94. https://doi.org/10.3238/arztebl.2008.0385
Ukena, Dieter, et al. "Bronchial asthma: diagnosis and long-term treatment in adults." Deutsches Arzteblatt international vol. 105,21 (2008): 385-94. doi: https://doi.org/10.3238/arztebl.2008.0385
Ukena D, Fishman L, Niebling WB. Bronchial asthma: diagnosis and long-term treatment in adults. Dtsch Arztebl Int. 2008 May;105(21):385-94. doi: 10.3238/arztebl.2008.0385. Epub 2008 May 23. PMID: 19626179; PMCID: PMC2696883.
Copy Download .nbib Format: NLM
QSPR analysis of some agonists and antagonists of α-adrenergic receptors.

Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents

Kawczak P, Bober L, Bączek T.
PMID: 25589825
Med Chem Res. 2015;24:372-382. doi: 10.1007/s00044-014-1130-x. Epub 2014 Jul 15.

Thirty-three compounds belonging to the sympatholytics and sympathomimetics were analyzed during the study. The biological activity data for the parameters of binding affinity to the α

Cite
Kawczak P, Bober L, Bączek T. QSPR analysis of some agonists and antagonists of α-adrenergic receptors. Med Chem Res. 2014;24:372-382doi: 10.1007/s00044-014-1130-x.
Kawczak, P., Bober, L., & Bączek, T. (2015). QSPR analysis of some agonists and antagonists of α-adrenergic receptors. Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents, 24372-382. https://doi.org/10.1007/s00044-014-1130-x
Kawczak, Piotr, et al. "QSPR analysis of some agonists and antagonists of α-adrenergic receptors." Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents vol. 24 (2015): 372-382. doi: https://doi.org/10.1007/s00044-014-1130-x
Kawczak P, Bober L, Bączek T. QSPR analysis of some agonists and antagonists of α-adrenergic receptors. Med Chem Res. 2015;24:372-382. doi: 10.1007/s00044-014-1130-x. Epub 2014 Jul 15. PMID: 25589825; PMCID: PMC4284397.
Copy Download .nbib Format: NLM
Long-term, induced expression of Hand2 in peripheral sympathetic neurons ameliorates sarcopenia in geriatric mice.

Journal of cachexia, sarcopenia and muscle

Rodrigues ACZ, Messi ML, Wang ZM, Bonilla HJ, Freeman WM, Delbono O.
PMID: 34546662
J Cachexia Sarcopenia Muscle. 2021 Dec;12(6):1908-1924. doi: 10.1002/jcsm.12790. Epub 2021 Sep 21.

BACKGROUND: The discovery of adrenoceptors, which mediate the effects of the sympathetic nervous system neurotransmitter norepinephrine on specific tissues, sparked the development of sympathomimetics that have profound influence on skeletal muscle mass. However, chronic administration has serious side effects...

Cite
Rodrigues ACZ, Messi ML, Wang ZM, et al. Long-term, induced expression of Hand2 in peripheral sympathetic neurons ameliorates sarcopenia in geriatric mice. J Cachexia Sarcopenia Muscle. 2021;12(6):1908-1924doi: 10.1002/jcsm.12790.
Rodrigues, A. C. Z., Messi, M. L., Wang, Z. M., Bonilla, H. J., Freeman, W. M., & Delbono, O. (2021). Long-term, induced expression of Hand2 in peripheral sympathetic neurons ameliorates sarcopenia in geriatric mice. Journal of cachexia, sarcopenia and muscle, 12(6), 1908-1924. https://doi.org/10.1002/jcsm.12790
Rodrigues, Anna Carolina Zaia, et al. "Long-term, induced expression of Hand2 in peripheral sympathetic neurons ameliorates sarcopenia in geriatric mice." Journal of cachexia, sarcopenia and muscle vol. 12,6 (2021): 1908-1924. doi: https://doi.org/10.1002/jcsm.12790
Rodrigues ACZ, Messi ML, Wang ZM, Bonilla HJ, Freeman WM, Delbono O. Long-term, induced expression of Hand2 in peripheral sympathetic neurons ameliorates sarcopenia in geriatric mice. J Cachexia Sarcopenia Muscle. 2021 Dec;12(6):1908-1924. doi: 10.1002/jcsm.12790. Epub 2021 Sep 21. PMID: 34546662.
Copy Download .nbib Format: NLM
Acetazolamide increases locomotion, exploratory behavior, and weight loss following social stress: .

Metabolism open

Woodman R, Student J, Malcolm T, Miller C, Lockette W.
PMID: 32812910
Metabol Open. 2020 Jan 13;5:100023. doi: 10.1016/j.metop.2020.100023. eCollection 2020 Mar.

Sympathomimetics are effective, centrally acting drugs that induce weight loss through their potent anorexic and locomotor properties. We reported that sympathomimetics antagonize catecholamine-dependent, alpha-2 adrenergic receptor-dependent signal transduction mediated by chloride/bicarbonate transport. We posit that other drugs that target...

Cite
Woodman R, Student J, Malcolm T, et al. Acetazolamide increases locomotion, exploratory behavior, and weight loss following social stress: . Metabol Open. 2020;5:100023doi: 10.1016/j.metop.2020.100023.
Woodman, R., Student, J., Malcolm, T., Miller, C., & Lockette, W. (2020). Acetazolamide increases locomotion, exploratory behavior, and weight loss following social stress: . Metabolism open, 5100023. https://doi.org/10.1016/j.metop.2020.100023
Woodman, Ryan, et al. "Acetazolamide increases locomotion, exploratory behavior, and weight loss following social stress: ." Metabolism open vol. 5 (2020): 100023. doi: https://doi.org/10.1016/j.metop.2020.100023
Woodman R, Student J, Malcolm T, Miller C, Lockette W. Acetazolamide increases locomotion, exploratory behavior, and weight loss following social stress: . Metabol Open. 2020 Jan 13;5:100023. doi: 10.1016/j.metop.2020.100023. eCollection 2020 Mar. PMID: 32812910; PMCID: PMC7424787.
Copy Download .nbib Format: NLM
Sex Differences in Substance Use and Misuse: A Toxicology Investigators' Consortium (ToxIC) Registry Analysis.

Substance abuse and rehabilitation

Beauchamp GA, Carey JL, Hurwitz MB, Tully BN, Cook MD, Cannon RD, Katz KD, Koons AL, Kincaid H, Greenberg MR.
PMID: 33061740
Subst Abuse Rehabil. 2020 Sep 29;11:23-31. doi: 10.2147/SAR.S263165. eCollection 2020.

BACKGROUND: Variations between male and female populations are previously reported in classes of harmfully used/misused drugs, severity of substance use disorder and risk of relapse. The aim of this study was to provide a review of bedside medical toxicologist...

Cite
Beauchamp GA, Carey JL, Hurwitz MB, et al. Sex Differences in Substance Use and Misuse: A Toxicology Investigators' Consortium (ToxIC) Registry Analysis. Subst Abuse Rehabil. 2020;11:23-31doi: 10.2147/SAR.S263165.
Beauchamp, G. A., Carey, J. L., Hurwitz, M. B., Tully, B. N., Cook, M. D., Cannon, R. D., Katz, K. D., Koons, A. L., Kincaid, H., Greenberg, M. R. (2020). Sex Differences in Substance Use and Misuse: A Toxicology Investigators' Consortium (ToxIC) Registry Analysis. Substance abuse and rehabilitation, 1123-31. https://doi.org/10.2147/SAR.S263165
Beauchamp, Gillian A, et al. "Sex Differences in Substance Use and Misuse: A Toxicology Investigators' Consortium (ToxIC) Registry Analysis." Substance abuse and rehabilitation vol. 11 (2020): 23-31. doi: https://doi.org/10.2147/SAR.S263165
Beauchamp GA, Carey JL, Hurwitz MB, Tully BN, Cook MD, Cannon RD, Katz KD, Koons AL, Kincaid H, Greenberg MR. Sex Differences in Substance Use and Misuse: A Toxicology Investigators' Consortium (ToxIC) Registry Analysis. Subst Abuse Rehabil. 2020 Sep 29;11:23-31. doi: 10.2147/SAR.S263165. eCollection 2020. PMID: 33061740; PMCID: PMC7532888.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 30 entries